HK1045110A1 - Magnetic targeted carrier - Google Patents

Magnetic targeted carrier

Info

Publication number
HK1045110A1
HK1045110A1 HK02106551.6A HK02106551A HK1045110A1 HK 1045110 A1 HK1045110 A1 HK 1045110A1 HK 02106551 A HK02106551 A HK 02106551A HK 1045110 A1 HK1045110 A1 HK 1045110A1
Authority
HK
Hong Kong
Prior art keywords
targeted carrier
magnetic targeted
magnetic
carrier
targeted
Prior art date
Application number
HK02106551.6A
Other languages
Chinese (zh)
Inventor
Raymond Rudge Scott
Lynn Kurtz Terri
Hugues Tapolsky Gilles
Li Yuhua
Original Assignee
Ferx Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferx Incorporated filed Critical Ferx Incorporated
Publication of HK1045110A1 publication Critical patent/HK1045110A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ceramic Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Paints Or Removers (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
HK02106551.6A 1999-10-18 2002-09-05 Magnetic targeted carrier HK1045110A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16029399P 1999-10-18 1999-10-18
PCT/US2000/028615 WO2001028587A2 (en) 1999-10-18 2000-10-13 Magnetic targeted carrier

Publications (1)

Publication Number Publication Date
HK1045110A1 true HK1045110A1 (en) 2002-11-15

Family

ID=22576298

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106551.6A HK1045110A1 (en) 1999-10-18 2002-09-05 Magnetic targeted carrier

Country Status (15)

Country Link
EP (1) EP1221974A2 (en)
JP (3) JP2003512336A (en)
KR (1) KR20020064299A (en)
CN (1) CN1287859C (en)
AU (1) AU772755B2 (en)
BR (1) BR0014877A (en)
CA (1) CA2387925A1 (en)
CZ (1) CZ293919B6 (en)
DE (1) DE1221974T1 (en)
ES (1) ES2182731T1 (en)
HK (1) HK1045110A1 (en)
IL (1) IL149004A0 (en)
MX (1) MXPA02003891A (en)
NZ (1) NZ518311A (en)
WO (1) WO2001028587A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808052D0 (en) 1998-04-17 1998-06-17 Secr Defence Implants for administering substances and methods of producing implants
EP1668424A4 (en) * 2003-09-12 2009-11-25 Onkor Pharmaceuticals Inc Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents
JP2007001865A (en) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd Fine particle enclosing fat-soluble medicine, method for producing the same and preparation containing the same
JP4982084B2 (en) * 2004-02-09 2012-07-25 株式会社サンギ Antitumor agent
GB0403856D0 (en) * 2004-02-20 2004-03-24 Algeta As Composition
US8142758B2 (en) 2004-02-20 2012-03-27 Algeta As Alpha-emitting hydroxyapatite particles
JP2006199810A (en) * 2005-01-20 2006-08-03 Yokohama National Univ Composite particle and method for producing the same
JP5097540B2 (en) * 2005-04-06 2012-12-12 株式会社サンギ Antitumor agent for intestinal absorption
AU2010246067B2 (en) 2009-05-04 2016-07-07 Eyepoint Pharmaceuticals Us, Inc. Porous silicon drug-eluting particles
US9333173B2 (en) * 2010-11-01 2016-05-10 Psivida Us, Inc. Bioerodible silicon-based devices for delivery of therapeutic agents
EP2891716B1 (en) * 2012-08-28 2018-03-28 Biocube System Inc. Porous solid phase for rapidly isolating biological molecules for nucleic acid amplification reaction from biological sample, and use thereof
CA2904077A1 (en) 2013-03-15 2014-09-25 Psivida Us, Inc. Bioerodible silicon-based compositions for delivery of therapeutic agents
JP6443907B2 (en) * 2014-02-17 2018-12-26 浩文 山本 Accumulation promoter for promoting accumulation of contrast agent in tumor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243652A (en) * 1978-07-14 1981-01-06 The Procter & Gamble Company Gastrointestinal scanning agent
ATE117829T1 (en) * 1988-05-24 1995-02-15 Anagen Uk Ltd MAGNETICALLY ATTRACTABLE PARTICLES AND PRODUCTION METHOD.
EP0772776B1 (en) * 1994-07-27 2000-03-22 Herbert Dr. Pilgrimm Superparamagnetic particles, process for their production and their use
WO1997001304A1 (en) * 1995-06-29 1997-01-16 Mallinckrodt Medical, Inc. Radiolabeled apatite particles containing a paramagnetic ion
JP3735990B2 (en) * 1997-01-28 2006-01-18 東ソー株式会社 Method for producing magnetic silica gel

Also Published As

Publication number Publication date
KR20020064299A (en) 2002-08-07
AU1090501A (en) 2001-04-30
CZ20021357A3 (en) 2002-11-13
CA2387925A1 (en) 2001-04-26
JP2003512336A (en) 2003-04-02
NZ518311A (en) 2003-10-31
CN1287859C (en) 2006-12-06
WO2001028587A3 (en) 2002-01-03
JP2005200426A (en) 2005-07-28
WO2001028587A2 (en) 2001-04-26
EP1221974A2 (en) 2002-07-17
CZ293919B6 (en) 2004-08-18
JP2003321348A (en) 2003-11-11
CN1420787A (en) 2003-05-28
IL149004A0 (en) 2002-11-10
DE1221974T1 (en) 2003-02-06
AU772755B2 (en) 2004-05-06
BR0014877A (en) 2002-06-11
ES2182731T1 (en) 2003-03-16
MXPA02003891A (en) 2002-12-09

Similar Documents

Publication Publication Date Title
EP1227718A4 (en) Animal carrier
SG123530A1 (en) Disk carrier
IL145199A0 (en) Permeability-modulated carrier referencing
GB2354022B (en) Carrier assembly
TW595806U (en) Tape carrier
EP1223947A4 (en) Targeted vectors
EP1142591A4 (en) Gene carriers
HK1045110A1 (en) Magnetic targeted carrier
CA97035S (en) Pet carrier
AU141509S (en) Clothes carrier
GB9812832D0 (en) Improved carrier
AU140979S (en) Article carrier
TW443667U (en) Improved magnetic structure
GB2359962B (en) Magnetic tags
GB9926920D0 (en) An information carrier
GB9921774D0 (en) Game carrier
GB0016825D0 (en) Information carrier
PL109670U1 (en) Carrier
GB2354216B (en) Game Carrier
PL109697U1 (en) Handly information carrier
CA87105S (en) Pet carrier
GB0015825D0 (en) Wheelchair-mountable shopping carrier
GB0004250D0 (en) Carrier Mount
GB0010127D0 (en) Improved carrier
GB0020609D0 (en) Improved carrier